Pasithea Therapeutics Corp. (KTTA)
NASDAQ: KTTA · Real-Time Price · USD
2.640
+0.010 (0.37%)
Dec 23, 2024, 2:48 PM EST - Market open
Pasithea Therapeutics Market Cap
Pasithea Therapeutics has a market cap or net worth of $3.34 million as of December 23, 2024. Its market cap has decreased by -53.57% in one year.
Market Cap
3.34M
Enterprise Value
-6.03M
1-Year Change
-53.57%
Ranking
Category
Stock Price
$2.64
Market Cap Chart
Since the IPO on September 15, 2021, Pasithea Therapeutics's market cap has decreased from $65.29M to $3.34M, a decrease of -94.88%. That is a compound annual growth rate of -59.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 3.33M | -56.80% |
| Dec 29, 2023 | 7.71M | -58.92% |
| Dec 30, 2022 | 18.77M | -51.55% |
| Dec 31, 2021 | 38.74M | -40.66% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Helius Medical Technologies | 3.39M |
| Avenue Therapeutics | 3.38M |
| Sharps Technology | 3.38M |
| China Pharma Holdings | 3.35M |
| Enveric Biosciences | 3.23M |
| GlucoTrack | 3.18M |
| Theriva Biologics | 3.17M |
| Psyence Biomedical | 3.17M |